awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36157266-57E5C326-57AB-4CA4-B675-5F55C38EBF1E
Q36157266-57E5C326-57AB-4CA4-B675-5F55C38EBF1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36157266-57E5C326-57AB-4CA4-B675-5F55C38EBF1E
Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093
P2860
Q36157266-57E5C326-57AB-4CA4-B675-5F55C38EBF1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36157266-57E5C326-57AB-4CA4-B675-5F55C38EBF1E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5922ba8c279b93538fe4fd98cdd7fdb87ff83d0c
P2860
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks